StairMed develops implantable brain–computer interface (BCI) systems, surgical robots, and ultra‑flexible neural electrodes (HNE) for clinical neurotechnology applications. Its platforms (including the WRS02 system) aim to restore motor control, support language reconstruction research, and enable long‑term, high‑channel neural recording with low tissue damage. The company targets clinical and rehabilitation markets, offering integrated implant hardware, signal acquisition systems, and brain‑control software for patients with paralysis and sensory deficits. StairMed is headquartered in Shanghai and emphasizes miniaturized, wireless implant designs and self‑developed surgical robots for implantation.
1
Round
1
Industry
3
Tags
Oct 28, 2026
Latest raise
Funding activity · 1 round
Oct 28, 2026
CNY 1.4B
Series C+
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
